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ABSTRACT 
 
Objectives: (1) To report the results of a pharmacist-directed cardiovascular risk management program; and (2) to identify obstacles 
faced by the pharmacists in the program implementation.  
 
Methods:  The collaborators in this study included two local unions, a health benefit consulting company, and a community 
pharmacy.  A total of 750 union workers with cardiovascular risk were informed about the cardiovascular risk management program.  
The program lasted six months, and the participation was voluntary.  There were three group educational sessions with each session 
followed by a medication management service.   
 
A staff person of the health benefit consulting company and two pharmacists were interviewed via telephone.  The interview 
questions were created according to the Gaps Model of Service Quality.  The Gaps Model theorizes five gaps among consumer 
expectations, consumer perceptions, management perceptions of consumer expectations, service quality, service delivery, and 
external communications to consumers.  
 
The following data were collected: (1) types and quantity of drug therapy problems, (2) pharmacists’ recommendations and 
prescribers' response, (3) patients’ quality of life, disability days, and sick days, and (4) the experience of involved parties.  Descriptive 
statistics were calculated. 
 
Results: Fifteen union workers participated in the program.  For the participants, 35 drug-related problems were identified, with 
“need for additional therapy” and “dose too low” being the most common problems.  To address these drug-related problems, 
pharmacists made 33 recommendations to prescribers, and prescribers accepted 55% of the recommendations.  
 
According to the interviews, there were three barriers faced by pharmacists to implement the program: lack of consensus about the 
recruitment, union workers’ unawareness of the program’s benefits, and limited support from the unions and the health benefit  
consulting company. 
 
Conclusions: It was difficult to recruit participants into the program.  Clear agreement among collaborators on both the program’s 
benefits and the specific roles of each collaborator may be the key to successfully implement similar programs in the future.   
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Introduction  
 
Seventy-nine million Americans suffer from cardiovascular 
diseases (CVD), and both the direct costs and indirect costs of 
CVD in the U.S. were estimated to be $432 billion in 2007.
1
  
Lost productivity was one primary cause for such economic 
burden 
1
, indicating that CVD is common among U.S. workers.  
CVD risk factors include modifiable and non-modifiable 
Case Study PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                              2010, Vol. 1, No. 1, Article 10                   INNOVATIONS in pharmacy   2 
 
factors.  Modifiable factors such as elevated cholesterol and 
blood pressure can be treated or controlled long before the 
onset of CVD.  To avoid the negative outcomes of CVD for at-
risk workers, health professionals need to conduct 
interventions to manage modifiable CVD risk factors.   
Community pharmacists have effectively provided 
cardiovascular risk management services.  For instance, 
community pharmacists contributed to improved patients’ 
health outcomes, in the Asheville Diabetes Management 
Program and Project ImPACT: Hyperlipidemia.
2,3
  The 
Asheville Diabetes Management Program used a longitudinal 
pre-post cohort design, and reported improvement in 
hemoglobin A1c for patients and a reduction in direct medical 
costs for employers.
2
  Project ImPACT was an observational 
study, in which patients achieved high persistence and 
compliance with dyslipidemic therapy.
3
  In addition, 
community pharmacists have provided workplace-based CVD 
risk management programs.
4,5
  In one on-site CVD risk 
management program, Heart Smart, pharmacists provided 
disease and lifestyle education, identified drug therapy 
problems, and measured blood pressure, pulse, and weight.
4
  
Similarly, in another on-site program, pharmacists provided 
education about heart disease, identified drug therapy 
problems, and performed routine blood pressure, pulse and 
weight measurements.
5
   
 
Yet, according to our knowledge, only two studies have 
reported the implementation and impact of a pharmacist-
directed cardiovascular risk program tailored for working 
adults.
4,5
  Lack of such evidence is important, because, until 
the services are established and the positive impact is 
revealed, interventions by community pharmacists to address 
cardiovascular risks for the workforce will have little support.  
Therefore, studies are needed to develop the procedure or 
assess the impact of pharmacist-directed services to reduce 
cardiovascular risk. 
 
 
This study was a pilot project to evaluate a new pharmacist-
directed cardiovascular risk management program for union 
workers.  The care model relied on both group education and 
medication management services provided by community 
pharmacists.  Pharmacists were used in the program because 
pharmacists are able to manage CV conditions, especially the 
medication-related component of care.  The specific 
objectives of this study were to:  
 
(1) report the results of the program in terms of drug-
related problems and patient quality of life; and 
(2) identify obstacles faced by the pharmacists in the 
program implementation.  
 
 
Methods 
 
Program description 
The collaborators in this program included one local union of 
electricians, one local union of plumbers, a health benefit 
consulting company, and a community pharmacy.  Different 
from previous workplace-based CVD risk management 
programs 
4,5
, the emphasis on the partnership of the three 
parties made this program unique.  First, the unions, the 
pharmacy, and the health benefit consulting company 
discussed the feasibility of this program and how to ensure 
confidentiality of patients’ information.  After obtaining the 
unions’ approval for the program, the pharmacy and the 
consulting company determined the inclusion and exclusion 
criteria of potential participants (Appendix A).  The inclusion 
criteria were proposed according to the inclusion criteria of 
Iowa Medicaid Pharmaceutical Case Management.
6
 The 
exclusion criteria were proposed to ensure the cardiovascular 
risks of participants were manageable by the program.  Using 
diagnostic codes of medical claims, the consulting company 
identified 750 union workers with cardiovascular risk.  All 750 
union workers met both the inclusion and exclusion criteria.  
Next, the pharmacy conducted a mass mailing, sending the 
identified workers a letter describing the cardiovascular risk 
management program and inviting them to participate 
(Appendix B).  In addition, the pharmacy made follow-up 
phone calls to these workers, inviting them to participate.  
The participation was voluntary.   
 
The cardiovascular risk management program lasted six 
months, and all sessions of group education and medication 
management services took place in the union halls.  There 
were three group educational sessions that were 
approximately an hour in length.  Each education session was 
conducted by a pharmacist and topics addressed included 
dietary strategies, life style changes, risk management 
strategies, and medication management tips.  The pharmacist 
prepared for each session based on his or her clinical 
experiences.  The sessions occurred during month 1 through 
month 3.   
 
Following the group educational sessions, the participants 
met one-on-one with a community pharmacist to receive the 
medication management services.  That is, to have all of their 
medications reviewed and cardiovascular risk factors 
monitored.  When a drug-related problem was identified in 
the comprehensive medication review, a plan was developed 
by the pharmacist to address it, and then the plan was 
implemented by the pharmacist, after working with the 
patient and the prescriber.  The procedures and 
documentation of this program were standardized, based on 
the pharmacy’s previous experience in Iowa Medicaid 
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Pharmaceutical Case Management.
6,7
  Participants were 
verbally encouraged to attend all sessions of group education 
and medication management services, but no incentives were 
provided to participants.  
 
Data collection and analyses 
Data collected in the study included (1) types and quantity of 
drug therapy problems, (2) pharmacists’ recommendations 
and physicians’ response, (3) patients’ quality of life, disability 
days, and sick days, and (4) the experience of involved 
parties.  Table 1 shows the data source for each variable.  A 
survey was used to collect patient self-reported measures 
including quality of life, disability days, and sick days.  
Descriptive statistics like frequency, means, and standard 
deviations were calculated.   
 
To better understand the experience of involved parties, 
telephone interviews were conducted with two pharmacists 
employed by the pharmacy and a staff person employed by 
the consulting company.  On average, each interview lasted 
about 20 minutes.  A union member participant was also 
invited for a telephone interview, but did not respond to 
repeated invitations.  Each interview was audio recorded in 
MP3 format, and the audio recordings were reviewed in their 
entirety by the interviewer three times.  The recordings were 
not transcribed word for word.  Instead, direct quotes were 
written down from the recordings when they were relevant 
to the interview questions.  This study was approved by the 
University of Iowa Institutional Review Board. 
 
The interview questions (Appendix C) were created according 
to the Gaps Model of Service Quality (Figure 1).
8
  The Gaps 
Model theorizes the process of a service from the 
perspectives of both the consumer and the marketer.  There 
are five possible gaps or differences in the provision of a 
service – Gap 1 between consumer expectations and 
management perceptions of consumer expectations, Gap 2 
between management perceptions and service quality, Gap 3 
between service quality and service delivery, Gap 4 between 
external communications to consumers and service delivery, 
and Gap 5 between consumer expectations and consumer 
perceptions.  The Gaps Model was used because (1) the 
community pharmacy and the health benefit consulting 
company represented the side of the marketer, (2) the 
participants represented the side of consumer, and (3) the 
process of providing this program was similar to the process 
outlined in the model. 
 
Different interview questions related to the Gaps Model were 
developed for the pharmacists and the health benefit 
consulting company staff person, respectively.  The 
consulting company was considered to have a role in possible 
Gaps 1 and 4, and the pharmacy was considered to have a 
role in possible Gaps 2 and 3.  This was because the 
consulting company worked with both the pharmacy and the 
unions, while the pharmacy only worked with the consulting 
company and did not have direct contact with the union 
members or management during program provision.  In 
addition to the questions related to the Gaps Model, general 
questions regarding the effects of the program and lessons 
learned were developed for both the pharmacists and the 
staff person.   
 
Results 
 
From the 750 union workers contacted, 15 participated in the 
cardiovascular risk management program.  These participants 
mentioned that they were concerned about their health and 
were engaged in managing their CV conditions by visiting 
physicians regularly.  Eleven of them attended all three 
sessions of the program, and four did not attend the third 
session.  For these 15 participants, 35 drug-related problems 
were identified during 6 months of program implementation, 
with “need for additional therapy” and “dose too low” being 
the most common problems (Table 2).  To address these 
drug-related problems, pharmacists made 33 
recommendations to prescribers, which primarily were 
medication addition and dose change (Table 3).  Prescribers 
accepted about 55% of pharmacists’ recommendations.    For 
the first and second visits, the majority of participants rated 
their health to be good (Table 4).  
 
The telephone interviews, with two pharmacists and a staff 
member from the consulting company, presented an 
informed view about the program implementation.  Direct 
quotes from each interview were presented in Table 5.  Such 
information revealed three barriers faced by pharmacists to 
provide cardiovascular risk management services for union 
workers.  These barriers included lack of consensus about 
participant recruitment, union workers’ unawareness of the 
program’s benefits, and limited support from the unions and 
the health benefit consulting company.  
 
Discussion 
 
This program relied on group education and medication 
management services.  Yet only 15 participants were 
recruited, despite the efforts of sending out invitation letters 
and performing follow-up phone calls.  In the proposal for the 
program, it was expected that up to 100 participants would 
be recruited.  Originally there was a plan to evaluate the 
impact of group education and medication management 
services on the cardiovascular risks of union workers.  Due to 
the limited number of participants, meaningful statistical 
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comparisons could not be made to assess the impact of the 
program.   
 
According to the interviews, there were three barriers faced 
by pharmacists to recruit participants or implement the 
program.  First, among the unions, the consulting company, 
and the pharmacy, there was lack of consensus about the 
recruitment or the values of the program.  The pharmacy 
regarded the program as an approach to improve patient 
outcomes and reduce healthcare costs, but this view was not 
well perceived by the unions and the consulting company.  
After getting a low response rate from eligible workers, the 
pharmacy put forward the idea to incentivize participants or 
make the program mandatory.  However, the consulting 
company was unwilling to provide incentives due to potential 
concerns which could have been raised by healthy union 
members, and the unions’ management’s reluctance to ask 
members to “force” participation in the program (which 
could only be accomplished by a majority vote at a regularly 
scheduled union meeting).   
 
Second, union workers did not comprehend the expected 
health benefits of the program and the time requirement to 
attend all sessions might have been an obstacle for them.  
When the pharmacy made follow-up phone calls, most at-risk 
workers did not know why they should participate in the 
program.  Some workers also commented that it was 
inconvenient for them to participate because of the time 
needed.   
 
Third, the recruiting efforts performed by the pharmacy, an 
outside source for the union workers, were mostly unilateral.  
The unions and the consulting company could have 
contributed to the recruitment.  For example, the consulting 
company could have advocated for the program when the 
response rate was found to be low by participating in the 
mailing and follow-up phone calls.   
 
These three barriers corresponded to Gaps 1, 3, and 4 in the 
Gaps Model.  Lack of consensus about the recruitment was 
related to Gaps 1 and 4, union workers’ unawareness of the 
program’s benefits was related to Gap 1, and limited support 
from the unions and the consulting company was related to 
Gaps 3 and 4.  Zeithaml et al. proposed a set of constructs 
which could impact each gap, with each construct consisting 
of multiple variables.
9
 For example, for Gap 1, upward 
communication is a construct, and this construct has three 
variables: extent of employee-to-manager communication, 
extent to which inputs from contact personnel are sought, 
and quality of contact between top managers and contact 
personnel.  In this study, it was likely that Gap 1 was caused 
by lack of upward communication from union workers to 
unions.  Gap 3 was caused by lack of teamwork and role 
ambiguity among the pharmacy, the consulting company and 
the unions.  Gap 4 was caused by lack of horizontal 
communication among the pharmacy, the consulting 
company and the unions.   
 
There also were three lessons learned from the experience 
which could be useful for other community pharmacists who 
are interested in providing similar services.  First, at the 
beginning of the program, all parties should reach clear 
agreement about the expected benefits of the program, 
specific roles of each party, and how to motivate 
participation.  All parties should meet together to discuss 
these issues, document the consensus, and comply with the 
agreement in the program implementation.  In addition, 
potential participants of the program should be included in 
the program design process.  Second, in addition to invitation 
letters and follow-up phone calls for recruitment, 
pharmacists could have attended union meetings to promote 
the program in person.  In these meetings, pharmacists could 
have had face-to-face contacts with at-risk workers and made 
them aware of the program’s benefits.  Moreover, those 
workers who signed up for the program could have 
encouraged their peers to participate.  These two lessons can 
improve both upward communication and horizontal 
communication, and reduce role ambiguity.  Therefore, Gaps 
1, 3 and 4 would be addressed.  Third, it may be better to 
provide medication management services in the pharmacy 
instead of union halls.  It was inconvenient for the pharmacy 
to prepare and transport equipment and materials to union 
halls and some participants were confused about the time 
and place of appointments, as two unions, with separate 
locations, were involved.  In addition, some participants were 
concerned about privacy in an open space such as the hall.   
 
In spite of the limited number of participants, the recruitment 
issue did not negatively impact the relationship among all 
parties involved.  Through the consulting company, the 
pharmacy provides annual health screenings for union 
workers.  In addition, the pharmacy considered implementing 
the program to be a good business decision and used this 
program to promote similar services to other organizations.   
 
One limitation of this study was that union workers who 
participated in the program, or those who did not participate, 
were not interviewed.  That is, the consumer side of the Gaps 
Model was not assessed.  The participants were asked 
whether they would like to be interviewed and only one 
expressed interest.  However, the participant did not respond 
to the repeated invitations to conduct the interview.  A 
direction for future research is to describe the experiences of 
participants in detail.  For example, researchers can describe 
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a patient’s drug-related problems at the beginning of a 
program, the recommendations made by the pharmacist for 
the patient, which recommendations were accepted by 
his/her prescriber, and how drug-related problems were 
addressed.  Another direction is to compare the reasons of 
participating, versus not participating, by interviewing both 
participants and non-participants.   
 
Conclusions 
 
The development of a new pharmacist-directed 
cardiovascular risk management program for union workers  
was evaluated, which relied on both group education and 
medication management services.  It was difficult to recruit 
participants in the program.  Using telephone interviews with 
involved parties, three obstacles faced by pharmacists in the 
program implementation were identified: lack of consensus 
about the recruitment, union workers’ lack of awareness of 
the program’s benefits, and limited support from the unions 
and the consulting company.  Clear agreement among 
collaborators on both the program’s benefits and the specific 
roles of each collaborator may be the key to overcome these 
barriers in the future.   
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Figure 1 The Gaps Model of Service Quality 
 
                         
Source: Parasuraman A, Zeithaml VA, Berry LL. A conceptual model of service quality and its implications for future research. J Mark. 
1985; 49:41-50. 
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Table 1 Variables and Data Sources 
 
 
Variables Sources 
Types and quantity of drug therapy problems 
a 
Patient charts from the pharmacy 
Pharmacists’ recommendations and prescribers’ response 
a 
Patient charts from the pharmacy 
Quality of life 
a 
Patient surveys 
Disability days 
a 
Patient surveys 
Sick days 
a 
Patient surveys 
Experience of involved parties 
b 
Telephone interview 
 
Note: 
a
 Data collected at each participant’s visit during 6 months of program implementation. 
           
b
 Data collected after 6 months of program implementation.  
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Table 2 Frequency of Drug-Related Problems 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drug-Related Problem Category  Frequency (%) 
Adherence  
Non-adherence 2 (5.7) 
Indication  
Need for additional therapy 18 (51.4) 
Unnecessary drug therapy 1 (2.9) 
Duplication 2 (5.7) 
Safety  
Drug interaction 1 (2.9) 
Dose too high 3 (8.6) 
Effectiveness  
Dose too low 8 (22.9) 
Total 35 (100) 
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Table 3 Pharmacists’ Recommendations to Prescribers and Prescribers’ Response 
 
 
Pharmacist 
Recommendation 
Recommendation 
Made 
Frequency (%) 
Prescriber Response 
and Acceptance 
Frequency (%) 
Prescriber Response 
but No Acceptance 
Frequency (%) 
No Prescriber 
Response 
Frequency (%) 
Dose Change 11 (33.3) 5 (15.2) 0 (0) 6 (18.2) 
Medication cessation 3 (9.1) 2 (6.1) 1 (3.0) 0 (0) 
Medication addition 19 (57.6) 11 (33.3) 4 (12.1) 4 (12.1) 
Total 33 (100) 18 (54.5) 5 (15.2) 10 (30.3) 
 
Note: The total number of recommendations made, 33, was used as denominator to calculate each percentage. 
Case Study PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                              2010, Vol. 1, No. 1, Article 10                   INNOVATIONS in pharmacy   11 
 
 
Table 4 Participants’ Quality of Life, Disability Days, and Sick Days 
 
 
Rating health in the past month 
 
Rating Visit 1 Visit 2 Visit 3 
Excellent 0 0 0 
Very Good 5 4 3 
Good  8 10 4 
Fair 2 1 1 
Poor 0 0 0 
Non-responder 0 0 7 
Total 15 15 15 
 
Rating health in the past month compared with peers 
 
Rating Visit 1 Visit 2 Visit 3 
Excellent 0 0 0 
Very Good 4 6 4 
Good  9 7 3 
Fair 2 2 1 
Poor 0 0 0 
Non-responder 0 0 7 
Total 15 15 15 
 
Note: 1. On the first visit, 2 patients claimed to have at least 1 disability day in the past month.  No patients reported disability  
               days on the second and third visits. 
           2. On the first visit, 2 patients claimed to have 2 sick days in the past month.  On the second visit, 4 patients claimed to  
               have 2 sick days in the past month.  No patients reported disability days on the third visit.  
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Table 5 Quotes from Telephone Interviews which were related to the Gaps Model
a 
 
Question: How did you recruit union workers for the project?  Why were not more patients recruited? (Addressing Gap 
1) 
Answer from the staff person at the consulting company: 
 
“I had access to the medical and pharmacy claims for union workers.  In meeting with the pharmacists, we determined 
certain ICD-9 coding that would target certain population.  I had set up a computer that I could query by diagnostic 
codes and sort out the population.  We generated a list with each of the diagnostic codes.” 
 
“We ended up with 750 (people).  We sent letters to those people, and then the pharmacy students who were doing 
the rotation at the pharmacy actually made phone calls to all those people.” 
 
“We were dealing with a population with high incidence of smoking, high cholesterol, and hypertension.  It was also a 
population, because of their work situation, that does not have exposure to wellness programs and healthy lifestyle 
choices.  So they tended to ignore this when we sent letters out to them.  The other thing is they had self-funded 
plans, so the people we were dealing with often times were those whom we knew on a one-to-one basis.  They were 
hesitant to enroll in a program like this, thinking that ‘big brother’ is looking at this information, even though we made 
sure it was confidential.  They think someone is looking at it and may use it against them in job placement or 
whatever.” 
Question: Did you standardize the service provision such as group education and medication management?  If yes, 
how? (Addressing Gap 2) 
Answer from Pharmacist 1:  
 
“We used the forms and processes we have developed for Iowa Medicaid Pharmaceutical Case Management.  So we 
used basically the same processes for the cardiovascular risk management program.  We used similar forms, and 
modified them for this program.” 
 
“We also developed a protocol for us to follow as far as what we do at each visit and the documentation of the 
outcomes we should be collecting at each visit.  We thought about the outcomes we wanted to collect before we 
actually started the program.  The protocol was for making sure that we collected the information we should be 
collecting each time we saw the patient.” 
 
Answer from Pharmacist 2: 
 
“We did standardize group education.  We had three sessions of group education that participants were invited to.”   
 
“For medication management, we had a little bit of standardization in the sense that we followed the same format 
and used the same forms.  But obviously, people had different concerns, questions, and disease states, which led the 
conversation into different directions.  (For medication management) It was the first time we had done a large 
employer group.” 
Question: How did you promote the service? (Addressing Gap 3) 
Answer from Pharmacist 1:  
 
“We worked with the health benefit consulting company, and they gave us a mailing list.  We started off by sending a 
mass mailing to participants who met the eligibility criteria.  And then, we also called the individuals.  We spent a lot 
of time doing phone calls to follow up people whom we did not hear anything back from.” 
 
“We wanted to work with the health benefit consulting company or the unions to help promote it.  But they did not 
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really want to be a part of the promotional process.  So a lot were left to our court to figure out how to best reach 
out to the patients, and the only thing that was given to us was a mailing list.  So the best way was – we sent out a 
letter and ended with follow-up phone calls.” 
 
Answer from Pharmacist 2:  
 
“We did a larger employer mailing, advertising sort of health fair services as well as medication management services 
for employer group.  Then we met with this particular employer group in a meeting to discuss what they were 
looking for and what we could offer before we set up the project.”  
 
“We didn’t do traditional advertising, marketing on radio or TV.  What we sent out was a packet in which we put 
together the information that included an introductory letter.  (In the packet) We had a list of services we can offer 
and pricing information in there.”   
Question: During the project, did you contact the health benefit consulting company about the limited number of 
patients recruited?  If you did, what was their response?  Was there any barrier in the communication with the health 
benefit consulting company? (Addressing Gap 3) 
Answer from Pharmacist 1: 
 
“We contacted the health benefit consulting company about the limited participants.  They were disappointed as 
well.  But they really did not offer much assistance.  Again, we were left trying to figure out how to increase the 
acceptance of it.  We did the best we could to try to call people, and do follow-up phone calls.”  
 
“The other thing is, it was really besides us letting them (union workers) know what the benefits of participation 
might be to them. There was no incentivization by either the health benefit consulting company or the unions for 
participants.  Because of that, people did have to come to the sessions on their own time.  We had to figure out a 
spot which might be convenient for them.” 
 
“I don’t think there were barriers in the sense of communication.  I think it was more of what we valued as 
pharmacist, compared to what they valued as the health benefit consulting company, and compared to what the 
unions valued.  I don’t think we were on the same page as far as what could be the benefits of the program.” 
 
“It would be better if the unions or the health benefit consulting company were involved with the mailing, or even 
the follow-up phone calls.  Because we were outside source, and most union workers did not know who we were to 
begin with.”  
 
“I don’t think we did a good job communicating what the value (of the program) could be, and what we need them to 
do to make it successful.  Again, it was not a barrier for communication, maybe just the right thing not 
communicated.”   
 
Answer from Pharmacist 2:  
 
“We were in contact with the health benefit consulting company throughout the whole process.  The recruiting 
process was left to us.  They gave us a list of names of people that would be eligible based on the criteria we set 
forth, and then me and some pharmacy students did the most of the calling”.   
 
“When we were getting poor response, we did have phone conversation with them.  They were not surprised about 
that response from that population as much as we were.  But there was no real help from that end, kind of ‘you get 
what you get’.  There was no way they were willing to come in to add motivation or incentive for people to join the 
program.”   
 
“I think they wanted to recruit more people, but they were not sure how to proceed.  When we were talking about 
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a
 See Appendix C for interview questions.  Pharmacists were asked questions addressing Gaps 2 and 3.  And the staff person at the 
health benefit consulting company was asked questions addressing Gaps 1 and 4.  
incentive, their concern was ‘how do you incent someone to be in the program and not incent those who don’t 
qualify for the program’.  Because it was like saying to someone ‘Hello, you are healthy, and you are going to be 
punished because these people who are not healthy are costing us money and we are going to incent them’. 
 
“I believe the unions talked about the program in their union meetings.  They talked about it, but there was no real 
campaign, I guess, that was able to sway the members’ feeling towards participating.  When we talked to people, it 
was mostly ‘I see a doctor.  I’m OK.  I don’t need to see you’.  Kind of the response we got.” 
 
“From the beginning toward the end of project, there was a change in staffing (at the health benefit consulting 
company).  The person whom we were dealing with initially left the company.  They did not really replace her, at 
least not right away, with anybody.  So trying to communicate on things that she had done, nobody really knew what 
was going on.  That was kind of a barrier.  But for most part that happened, the project was wrapped up.” 
Question: Prior to or during the recruitment, how did you promote the service among union workers? (Addressing Gap 
4) 
Answer from the staff person at the consulting company: 
 
“We initially sent a letter out, explaining the program to the selected population.  Not to all participants to the plan, 
just to those we had selected according to the ICD-9 codes.  That was the really only promotion the health benefit 
consulting company did.” 
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Appendix A. Patient Inclusion and Exclusion Criteria 
 
 
Patient inclusion criteria:  
—Diagnosis of cardiovascular disease (e.g. diabetes, coronary heart  
disease, hypertension, and dyslipidemia) 
—Age ≥ 18 
—Taking four or more chronic oral medications 
 
Patient exclusion criteria: 
—Renal dysfunction (CrCl<30 ml/min) or dialysis patient 
—Hepatic disorder (liver function test > 3 x normal) 
—Significant cardiac complications (Stage IV HF) 
—Legal blindness 
—Dementia 
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Appendix B. Letter Sent to Eligible Union Workers 
 
Date 
 
Name 
Address 1 
Address 2 
City, State, Zip 
 
Dear Title Last Name: 
 
Participating Body Names, in collaboration with Health Benefit Consulting Company Name and Pharmacy Name, is excited to 
announce a new health-related service available to eligible participants.  This service is a pharmacist-directed cardiovascular risk and 
medication management program that includes group education and one-on-one medication management meetings with trained 
pharmacists. 
 
Cardiovascular disease (CVD) continues to be a leading cause of death in the United States—claiming over 900,000 lives annually.  
Approximately 70 million Americans have some form of CVD—including hypertension, coronary heart disease, and high cholesterol.  
Coronary heart disease remains the leading cause of premature disability among working adults.  In 2005, it is estimated that the 
costs of cardiovascular disease will approach $400 billion.  This includes health care expenditures and loss of productivity from death 
and disability. 
 
Several risk factors have been identified that increase the risk of CVD.  Some risk factors cannot be changed (e.g. age, gender, and 
heredity); whereas others can be treated or controlled (e.g. smoking, elevated cholesterol and blood pressure, diabetes, physical 
inactivity, and obesity).  Many of these risk factors often present early in life when preventative measures may make a large 
difference—before the onset of disease. 
 
Participating Body Names believe that this new program can impact the health of the participants.  The ultimate goal is to improve 
cardiovascular risks and promote healthier lifestyles, in a more timely and cost efficient manner, for those who participate in this six 
month program. 
 
Those who sign up for the program will participate in three sixty-minute group educational programs that provide an overview on 
the following topics: 
 Dietary Strategies and Lifestyle Changes 
 Cardiovascular Risk Management Strategies 
 Medication Management Strategies 
These educational programs will occur during the months of September to November.   
 
Following the group educational sessions, at pre-scheduled times at___________, participants will meet one-on-one with a clinical 
pharmacist to have their medications reviewed, risk factors monitored, and questions answered.  These meetings will occur at the 
start of the program and then at 1 month and 4 month intervals.  The information collected at these sessions will include risk factors, 
blood pressure, lipid (cholesterol) levels, blood glucose, and other pertinent clinical information.  All information is completely 
confidential. 
 
This program is available at no charge to you.  The group educational and medication management sessions will be scheduled at a 
time and place convenient for the majority of participants.  
 
Thank you for your timely response to this letter.  If you would like to participate in this program, please return the attached form in 
the enclosed envelope.  
 
If you have any questions, please call______________________.  We look forward to working with you to improve your risk for 
cardiovascular disease and to improve your quality of life. 
 
Sincerely,
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Appendix C. Interview Questions 
 
 
For Pharmacists at the community pharmacy:  
(1) Did you standardize the service provision such as group education and medication management?  If yes, how? (Addressing Gap 2)  
(2) How did you promote the service? (Addressing Gap 3)   
(3) During the project, did you contact the health benefit consulting company about the limited number of patients recruited?  If you 
did, what was their response?  Was there any barrier in the communication with the health benefit consulting company? 
(Addressing Gap 3)  
(4) What effects does the project have in your practice and your relationship with the health benefit consulting company? (General 
question) 
(5) What lessons can be learned from the project? (General question) 
 
For the Staff Person at the health benefit consulting company: 
(1) How did you recruit union workers for the project?  Why were not more patients recruited? (Addressing Gap 1)  
(2) Prior to or during the recruitment, how did you promote the service among union workers? (Addressing Gap 4) 
(3) What effects does the project have in your relationship with the unions and the community pharmacy? (General question) 
(4) What lessons can be learned from the project? (General question) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
